3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
7
Colonic Neoplasms
6
Breast Neoplasms
5
Uterine Cervical Dysplasia
4
Urinary Bladder Neoplasms
4
Papillomavirus Infections
3
Neuroblastoma
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Anus Neoplasms
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Precancerous Conditions
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
HIV Infections
2
Interventions
Pemetrexed
9
Nivolumab
8
Cisplatin
8
Carboplatin
8
pembrolizumab
7
130-nm albumin-bound paclitaxel
7
Gemcitabine
6
padeliporfin
5
durvalumab
5
Paclitaxel
5
Bevacizumab
5
palbociclib
4
napabucasin
4
atezolizumab
4
Irinotecan
4
Fulvestrant
4
Fluorouracil
4
Cyclophosphamide
4
ribociclib
3
osimertinib
3
cobimetinib
3
alectinib
3
abemaciclib
3
Trastuzumab
3
Sunitinib
3
Radiosurgery
3
Drug Therapy
3
Docetaxel
3
Cetuximab
3
Anastrozole
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms by Site
×
Watchful Waiting
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled